These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 268620)

  • 1. Interaction between the third complement protein and cell surface macromolecules.
    Law SK; Levine RP
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2701-5. PubMed ID: 268620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary spherocytosis of man. Altered binding of cytoskeletal components to the erythrocyte membrane.
    Hill JS; Sawyer WH; Howlett GJ; Wiley JS
    Biochem J; 1982 Feb; 201(2):259-66. PubMed ID: 7082289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.
    Tamura N; Baba AS
    Immunology; 1976 Jul; 31(1):151-8. PubMed ID: 1027719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormality of glycophorin-alpha on paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Soldato CM; Rosse WF
    J Clin Invest; 1984 Apr; 73(4):1130-43. PubMed ID: 6231312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural release of covalently bound C3b from cell surfaces and the study of this phenomenon in the fluid-phase system.
    Venkatesh YP; Minich TM; Law SK; Levine RP
    J Immunol; 1984 Mar; 132(3):1435-9. PubMed ID: 6693771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosétte formation between human b lymphocytes and zymosan-C3 complexes using different complement sources.
    Kajdacsy-Balla AA; Mendes NF
    J Immunol Methods; 1976; 9(3-4):205-9. PubMed ID: 1082460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential coating of human red blood cells with C4 or C3 in a low ionic strength medium.
    Heier HE; Kornstad L; Nordhagen R
    Vox Sang; 1981; 41(4):249-54. PubMed ID: 6801858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The third (C3) and the fourth (C4) components of complement: labile binding site and covalent bond formation.
    Janatova J
    Ann N Y Acad Sci; 1983; 421():218-34. PubMed ID: 6586100
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of C3b, B, and D in the alternative pathway of complement activation.
    Nicholson A; Brade V; Schorlemmer HU; Burger R; Bitter-Suermann D; Hadding U
    J Immunol; 1975 Oct; 115(4):1108-13. PubMed ID: 240884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement (C3) receptor-bearing lymphocyte-mediated cytotoxicity and lymphotoxin responses.
    O'Neill P; Mackler BF; Wyde P
    Cell Immunol; 1975 Nov; 20(1):33-41. PubMed ID: 1081909
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the binding of complement to solid artificial surfaces in vitro.
    Wetterö J; Askendal A; Bengtsson T; Tengvall P
    Biomaterials; 2002 Feb; 23(4):981-91. PubMed ID: 11791932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
    Melamed J; Medicus RG; Arnaout MA; Colten HR
    J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
    Minta JO; Man D; Movat HZ
    J Immunol; 1977 Jun; 118(6):2192-8. PubMed ID: 864257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of hemolysis of erythrocytes by sodium dodecyl sulfate.
    Rozin VV
    Ann N Y Acad Sci; 2005 Jun; 1048():451-2. PubMed ID: 16154975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.